Al Malki, Monzr M. ; London, Kaitlyn ; Baez, Janna ; Akahoshi, Yu 
; Hogan, William J. ; Etra, Aaron ; Choe, Hannah ; Hexner, Elizabeth ; Langston, Amelia ; Abhyankar, Sunil ; Ponce, Doris M. ; DeFilipp, Zachariah ; Kitko, Carrie L. ; Adekola, Kehinde ; Reshef, Ran ; Ayuk, Francis ; Capellini, Alexandra ; Chanswangphuwana, Chantiya ; Eder, Matthias ; Eng, Gilbert ; Gandhi, Isha ; Grupp, Stephan ; Gleich, Sigrun ; Holler, Ernst ; Javorniczky, Nora Rebeka ; Kasikis, Stelios ; Kowalyk, Steven ; Morales, George ; Özbek, Umut ; Rösler, Wolf ; Spyrou, Nikolaos ; Yanik, Gregory ; Young, Rachel ; Chen, Yi-Bin ; Nakamura, Ryotaro ; Ferrara, James L. M. ; Levine, John E.
; Hogan, William J. ; Etra, Aaron ; Choe, Hannah ; Hexner, Elizabeth ; Langston, Amelia ; Abhyankar, Sunil ; Ponce, Doris M. ; DeFilipp, Zachariah ; Kitko, Carrie L. ; Adekola, Kehinde ; Reshef, Ran ; Ayuk, Francis ; Capellini, Alexandra ; Chanswangphuwana, Chantiya ; Eder, Matthias ; Eng, Gilbert ; Gandhi, Isha ; Grupp, Stephan ; Gleich, Sigrun ; Holler, Ernst ; Javorniczky, Nora Rebeka ; Kasikis, Stelios ; Kowalyk, Steven ; Morales, George ; Özbek, Umut ; Rösler, Wolf ; Spyrou, Nikolaos ; Yanik, Gregory ; Young, Rachel ; Chen, Yi-Bin ; Nakamura, Ryotaro ; Ferrara, James L. M. ; Levine, John E. 
Abstract
Graft-versus-host disease (GVHD) of the gastrointestinal (GI) tract is the main cause of nonrelapse mortality (NRM) after allogeneic hematopoietic cell transplantation. Ann Arbor (AA) scores derived from serum biomarkers at onset of GVHD quantify GI crypt damage; AA2/3 scores correlate with resistance to treatment and higher NRM. We conducted a multicenter, phase 2 study using natalizumab, a ...
Owner only: item control page
Altmetric